Skip to main content
logo
Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3250
-0.0250 (-7.14%)
Oct 7, 2026, 3:55 PM AEST

Cleo Diagnostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
44695044--
Market Cap Growth
-3.82%36.80%14.71%---
Enterprise Value
38594334--
Last Close Price
0.320.500.390.34--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
25.5539.9259.30207.25--
PB Ratio
8.7613.688.594.65--
P/TBV Ratio
9.3314.589.154.86--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
21.9334.4450.65159.30--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-----1.70-
Net Debt / Equity Ratio
-1.24-1.24-1.11-1.00-1.44-
Net Debt / EBITDA Ratio
1.111.111.612.62-0.82-
Net Debt / FCF Ratio
1.261.262.224.61-1.88-
Asset Turnover
0.250.250.100.04--
Quick Ratio
3.793.795.9319.400.13-
Current Ratio
3.803.805.9419.410.29-
Return on Equity (ROE)
-109.48%-109.48%-52.53%-88.99%--
Return on Assets (ROA)
-52.14%-52.14%-30.35%-41.55%--
Return on Capital Employed (ROCE)
-113.40%-113.40%-70.00%-38.80%180.20%-

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-13.53%-8.66%-7.98%-8.60%--
FCF Yield
-11.27%-7.22%-5.81%-4.65%--
Buyback Yield / Dilution
-3.29%-3.28%-9.53%-346.76%--